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a b s t r a c t
Carbon nanotubes (CNTs) represent promising vectors to facilitate cellular drug delivery and to overcome
biological barriers, but some types may also elicit persistent pulmonary inflammation based on their fibre
characteristics. Here, we show the pulmonary response to aqueous suspensions of block copolymer dis-
persed, double-walled carbon nanotubes (DWCNT, length 1–10 lm) in mice by bronchoalveolar lavage
(BAL) analysis, and BAL and blood cytokine and lung antioxidant profiling. The intratracheally instilled
dose of 50 lg DWCNT caused significant pulmonary inflammation that was not resolved during a 7-
day observation period. Light microscopy investigation of the uptake of DWCNT agglomerates revealed
no particle ingestion for granulocytes, but only for macrophages. Accumulating macrophage, multinucle-
ated macrophage and lymphocyte numbers in the alveolar region further indicated ineffective resolution
with chronification of the inflammation. The local inflammatory impairment of the lung was accompa-
nied by pulmonary antioxidant depletion and haematological signs of systemic inflammation. While
the observed inflammation during its acute phase was dominated by neutrophils and neutrophil recruit-
ing cytokines, the contribution of macrophages and lymphocytes with related cytokines became more
significant after day 3 of exposure. This study confirms that acute pulmonary toxicity can occur on expo-
sure of high doses of DWCNT agglomerates and offers further insight for improved nanotube design
parameters to avoid potential long-term toxicity.
 2013 Elsevier B.V. All rights reserved.
1. Introduction
A large number of engineered nanomaterials are currently being
investigated for their potential use in biomedical applications such
as diagnostics and drug delivery. Due to their one-dimensional
nanostructure, carbon nanotubes (CNTs) have shown promise to
facilitate cellular delivery and to overcome biological barriers [1].
In particular, single wall carbon nanotubes (SWCNTs), which con-
sist of only one carbon layer and thereby feature the smallest tube
diameter of only 1–2 nm, seem advantageous for drug delivery to
intracellular targets, since these CNT specimens may enter the cells
by non-specific, physical penetration of the cell membrane without
cytotoxic response [2–4]. On the other hand, the pharmaceutical
application of SWCNT is limited due to difficulties in covalent sur-
face functionalization without causing collateral damage to the
carbon backbone and thereby changing the tube morphology and
surface chemistry. The use of multi-walled (MWCNT) or already
double walled (DWCNT) carbon nanotubes could however avoid
these pitfalls [5]. Furthermore, DWCNT which have almost the
same outer diameter as SWCNT are not as rigid as MWCNT and
might therefore, just as SWCNT, be considered less toxic [6].
Besides these promising features, these new fibre materials
have raised concerns regarding potential pathogenic effects when
they gain access to the lung due to their asbestos-like appearance
[7–9] and therefore require individual testing. Independent
of particle shape, pulmonary exposure to sufficient doses of carbo-
naceous nanoparticles has been shown to trigger acute inflamma-
tory effects on the lungs dependent on the total particle surface
area, which might resolve after a few days [10–12]. Once aerosol-
ized and airborne, one of the most hazardous exposure routes is
the respiratory tract, where inhaled sub-100 nm particles may
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deposit in the periphery of the lungs and biopersist by insufficient
clearance [13]. Accordingly, there is also an increasing number of re-
ports on potentially adverse health effects of inhaled engineered
nanomaterials [8,14–16]. Interactions of CNTs with the lung tissue
have been reported to induce pro-inflammatory and even pro-fibro-
tic responses [17,18]. The needle-like shape of nanofibres is believed
to account for any long-term toxicity of certain types of these inno-
vative, elongated nanomaterials [19,20]. Given the known health
impact of mineral fibres (especially the fibrogenic and carcinogenic
risk of asbestos fibres), toxicological comparisons of asbestos with
fibre-like CNTs (in terms of the elongated shape) have been carried
out to assess whether certain CNTs pose a similar health risk
[9,11]. As a result, a threshold length of approximately 5 lmwas re-
cently suggested for nanofibre-induced acute pleural inflammation
in mice [21], while a threshold CNT length exceeding 15 lm has
been suggested to increase their toxic risk based on frustrated
phagocytosis studies [22,23]. Determining the fibre length, however
inside the lungs, remains challenging as well as whether individual
tubes or even agglomerated clusters of tubes building up fibres
should be considered is currently under discussion.
Besides shape, surface chemistry and purity of CNTs is a subject
of intense research [14]. In this context several reports have shown
that pristine, non-chemically functionalized CNTs can induce both
inflammatory and fibrotic reactions, either upon aspiration instilla-
tion or inhalation exposure [9,24–26]. A variety of nanotube types,
such as single-wall carbon nanotubes (SWCNTs) and multi-walled
carbon nanotubes (MWCNTs), are currently being extensively
studied, but no clear general conclusion can be drawn so far
regarding contributions of the number of carbon layers to CNT tox-
icity. Accordingly, a recent study concluded that certain types of
MWCNTs can induce mesothelioma and lung cancer, as much as
asbestos fibres do, due to their length and high rigidity [27].
Regarding the effect of chemical surface functionalization of nano-
tubes, even though significant improvement is obtained compared
to non-functionalized surfaces, more data are needed to determine
the contribution of the types of chemical modifications to their
overall toxicological profile.
Double-walled carbon nanotubes (DWCNTs) are rather excep-
tional representatives of CNTs and might be rated as posing similar
toxic risks to that of SWCNTs. Upon agglomeration, SWCNTs form
low density, wool-like clumped structures (but not necessarily
needle-like structures) as have been described for some types of ri-
gid MWCNTs [19]. For biomedical applications, functionalized
CNTs have emerged as a new family of nanovectors [1,28] and
DWCNTs as well as MWCNTs are preferred over SWCNTs for cova-
lent functionalization [5]. Even if short (<10 lm) and flexible
DWCNTs raise less concerns regarding fibre-toxicity characteris-
tics, their safety for pulmonary applications must still be validated
in detail.
Here, we explored the acute pulmonary response of intratrach-
eally instilled pristine, block-copolymer dispersed DWCNTs in
lungs of young and healthy mice. Since inflammation is known to
be the major acute effect of pulmonary particle deposition, we fo-
cused on the analysis of inflammatory cells and cytokines, locally
in the alveolar compartment of the lung, and systemically in the
blood and serum of mice, from 1 to 7 days after exposure. We fur-
ther investigated particle uptake and antioxidant depletion in lung
tissue. Our examinations showed that a dose of 50 lg of DWCNT
elicits significant, inflammatory responses in the lungs and the
blood, which does not resolve within 7 days after treatment.
2. Methods
Female BALB/cAnNCrl mice (Charles River Laboratories, Sulz-
feld, Germany), at the age of 10–12 weeks, were exposed to
50 lg pristine DWCNT suspensions in a volume of 50 ll vehicle
by intratracheal instillation as described earlier [11]. According
to the data sheet, DWCNTs (Nanocyl, Belgium; NC2100 series)
are characterised dimensions of 3.5 nm in diameter and between
1 and 10 lm in length, and carbon purity of over 90% and metal
oxide impurities below 10%. ICPMS analysis revealed 2.45% Fe
and 177 mg/kg Ni impurities in the DWCNT samples with Cd, Cr,
Cu and Zn below the detection limits of 8.18; 12.7; 26.8 and
38.2 mg/kg, respectively. The specific surface area (BET) was
660 cm2/g. The absence of any bioactive endotoxin contamination
was approved by LIMULUS assay and even more relevant by
in vitro studies with the LPS sensitive alveolar macrophage cell line
MHS. Since suspensions of pristine DWCNT tend to rapidly form
agglomerates in pure water and are thus not stable for instillation
application, we used the non-ionic surface-active polyol, Pluronic
F127 (Sigma–Aldrich, Germany) for dispersion. DWCNT were dis-
persed in pyrogen free, distilled water with 1% Pluronic F-127, son-
icated for 30 min and then further diluted 1:10 in water with 1% F-
127. Fig. 1 shows a transmission electron microscopy image of the
dispersed DWCNT sample. Particle suspensions were stable for
several minutes (Z-Average: 454 nm, PdI: 0.7; further details are
described elsewhere) and were kept in an ultrasonic water bath
and thoroughly mixed by vortexing just prior to instillation. Sham
groups received 50 ll vehicle (1% Pluronic F-127 solution). Animals
were treated humanely, and with regard to alleviation of suffering,
experimental protocols were reviewed and approved by the Bavar-
ian Animal Research Authority.
A total number of 30 mice where used, 8 for control, 5 for sham,
6 for day 1, 6 for day 3 and 5 for day 7. Mice were sacrificed 1, 3 or
7 days post-instillation with an overdose of ketamine/xylazin (1%/
0.1%) by exsanguination. Blood was drawn from the retro-orbital
plexus and collected in EDTA tubes (Sarstedt) for haematological
analysis using the ADVIA120 haematology system (Bayer Diagnos-
tics) and non-EDTA-covered tubes to gain serum for later cytokine
analysis. The lungs of the mice were lavaged with PBS solution
(37 C), and bronchoalveolar lavage (BAL) was processed, as previ-
ously described [11]. For each mouse, four lavage cell cytospins
were prepared; two used for cell differentiation by May-Grünwald
Fig. 1. Transmission electron microscopy image of the pluronic dispersed DWCNT
sample used for instillation.
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staining, and two were frozen at 80 C for subsequent immuno-
fluorescence staining.
The following 23 cytokines and chemokines (IL-1a, IL-1b, IL-2,
IL-3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12 (p40), IL-12 (p70), IL-13, IL-
17, CSF1/MCSF, CSF3/GCSF, IFN-g, CXCL1/KC, CCL2, CCL3, CCL4,
CCL5, CCL11/Eotaxin and TNF-a) were quantified in the BAL fluid
(BALF) and serum using Luminex technology (LINCOplex 23, Linco
Research, St. Charles, MO) as described in [12]. Glutathione (GSH)
and catalase activity levels in BALF were determined by high-per-
formance liquid chromatography (Shimadzu, USA), as described in
[29].
For immunofluorescence staining, cytospin slides were fixed
with methanol at 20 C for 10 min and with acetone (20 C)
for 1 min. The slides were washed twice in PBS and then blocked
with PBS containing 0.1% BSA for 10 min at room temperature, fol-
lowed by draining. For (i) macrophage and (ii) granulocyte detec-
tion, slides were incubated with (i) rat anti-mouse Mac-3
antibody (BD Pharmingen) and (ii) goat anti-rat Ly6G/Ly6C (BD
Pharmingen), in PBS containing 1% BSA for 60 min, and washed
three times in PBS. This step was followed by incubation with
the secondary antibodies Chromeo™ 642 Goat anti-Mouse IgG (Ac-
tive Motif) and Texas red (596 nm) anti-rat conjugate (Vector Labs)
at the recommended dilution, in PBS containing 1% BSA, for 30 min.
Subsequently, slides were washed three times with PBS. After
staining cell nuclei by DAPI (Invitrogen), one drop of aqueous
mounting medium was added on the cover slip and inverted care-
fully on a glass slide. Cell numbers and DWCNT agglomerate parti-
cles were counted using ImageJ (http://rsbweb.nih.gov/ij/) image
processing analysis, according to the procedure described previ-
ously [30]. The black carbon particles in a bright field image were
considered as DWCNT agglomerates. The bright field images were
inverted into a dark field to allow for superposition with respective
fluorescent images. To illustrate the uptake of DWCNT agglomerate
particles, bright spots (carbon particles) were highlighted by green
pseudocolour in the dark field, while the cytoplasma was shown by
red fluorescent staining with anti-Mac-3 or anti-Ly6G/Ly6C. For
quantification of DWCNT-particle laden cells, or more precisely,
particle-associated cells, BAL macrophages and granulocytes were
differentiated in pseudo-green particle free (negative) and pseu-
do-green particle associated (positive) cells.
All values are presented as mean ± standard deviations. Signifi-
cant differences between the two groups were evaluated by the
Student’s t-test or, between more groups, by one-way ANOVA.
We performed regression analysis as well as Tukey’s and Bonfer-
roni’s multiple comparison tests to identify the source of variance.
Cytokine levels are given as concentration changes relative to
sham, and for BALF levels, only changes over 10-fold (relative to
the sham group) were defined as biological significant. Statistical
analysis was performed with GraphPad Prism 5.0 (GraphPad Soft-
ware, USA). Statistical significance is marked as follows: p < 0.05;
p < 0.01; and p < 0.001.
3. Results and discussion
3.1. DWCNT cause persistent alveolar inflammation
Pharmaceutical functionalized DWCNT present a promising
vehicle for intracellular drug targeting. On that aim, not pristine
tubes as analysed here, but constructs with surface-functionaliza-
tion, employing target specific probes, peptides or other ligands,
are used to archive their pharmaceutical purpose. These pharma-
ceutical surface modifications will to a large extent also determine
the acute fate and biocompatibility of the materials. However, once
deposited in the lungs, and after a while in particular, the bioper-
sistent CNT-backbone may remain as high burden in the alveolar
region, where particle clearance is known to be poor (as reviewed
by [31]), and pulmonary inflammation is a sensitive response to
alveolar retained carbon nanoparticles with high surface area
[11]. For that reason, we have decided to study the inflammatory
response to pristine DWCNT in general, rather than that of a spe-
cific functionalization. On a related note, it may be mentioned that
COOH-functionalized SWCNTs have been shown to be even less
biocompatible and more toxic than the corresponding pristine
specimen [32–34].
In the present study, we show acute pulmonary inflamma-
tion in young and healthy mice upon intratracheal delivery of
pluronic-dispersed DWCNT. This pulmonary response is charac-
terised by a dynamic alveolar accumulation of neutrophil gran-
ulocytes on day 1 after instillation (Fig. 2) as assessed by
bronchoalveolar lavage (BAL). During the first week after expo-
sure, the number of neutrophilic BAL cells decreased from
239  10E3 cells on day 1, to 84  10E3 on day 3 after instilla-
tion, but climbed back up to 150  10E3 cells until day 7. Dur-
ing the same time interval, the number of macrophages and
lymphocytes increased continuously. As a result, the cellular
composition of leucocytes, recovered by BAL, changed most sub-
stantially during the acute response, with 64% neutrophils on
day 1, after DWCNT treatment. However, the fraction of neutro-
phils persisted at levels of 22% and 23% on day 3 and day 7
after treatment (Fig. 2). This lack of rapid resolution of the neu-
trophilic cell influx in the alveolar compartment of the lungs
strongly indicated a sustained inflammatory response induced
by DWCNTs. Another important indication of ineffective resolu-
tion and persistent inflammation was given by the accumula-
tion of multinucleated macrophages, a crucial sign of foreign
body reaction. Multinucleated macrophage numbers increased
significantly from day 3 on. Moreover, the gradually increasing
level of lymphocytes pointed to a disturbance of resolution of
the acute response. BAL cell samples from the untreated control
or sham group consisted almost exclusively of alveolar macro-
phages (95%). Sham exposure caused no inflammatory response,
but vehicle (1% Pluronic F-127) instillation apparently enhanced
the yield of BAL cell recovery about 2-fold, for macrophages,
neutrophils and lymphocytes (Fig. 2). Instillation of the Pluronic
F-127 detergent seems to increase the lavagability and recovery
of lung leucocytes from the airspace, which is in accordance
with its impact on cell adhesion which has been described for
endothelial cells in vitro [35].
Upon inflammation, newly recruited macrophages and neutro-
phils present the front-line of early inflammatory responses
against foreign materials in the lungs and accumulate in the air-
space. In contrast to alveolar macrophages, neutrophils are short
lived and, accordingly, their numbers decreased rapidly after day
1, whereas macrophages prevailed again from day 3 on. In fact,
macrophage numbers increased threefold from day 1 to day 7, as
did the numbers of lymphocytes which had been close to the
detection level during the initial state of inflammation.
The dynamic changes in alveolar leucocyte composition and
numbers were accompanied by the release of a number pro-
inflammatory cytokines, which were for IL-13, CSF3, CXCL1 and
CCL3 found with over 100-fold increased concentrations in BAL
fluid of DWCNT treated mice (BALF) (Fig. 3). The highest boost
was detected for CSF3 (GCSF, granulocyte colony-stimulating fac-
tor), reaching concentrations over 3000 pg/ml at day 1 after
DWCNT treatment (see Supplementary Table 1). However for the
acute phase cytokines CSF3 and IL-6, BAL levels also declined again
rapidly by day 7. CCL3 in contrast remained 100 times elevated
over the period of investigation, which matches with at day 7 still
high neutrophil counts. CCL2, the major macrophage recruiting
chemokine as well as Eotaxin, IFNg and IL-12 levels were charac-
terised by over time increasing BAL concentrations which could
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Fig. 2. Changes in macrophage, neutrophil, lymphocyte and multinucleated macrophage cell numbers in BAL after DWCNT exposure. The first bar chart illustrates changes in
the BAL cell composition as a percentage of the most abundant leucocytes (macrophages, neutrophils and lymphocytes). The remaining bar charts show changes in absolute
cell numbers. Statistical significance was analysed by one-way ANOVA and Tukey’s test, and changes relative to the sham group are highlighted (p < 0.05, p < 0.01,
p < 0.001). The lower left picture shows representative images of cytospin slides of control, sham (day 1) and DWCNT-treated mice after 1, 3 and 7 days. Arrows point to
alveolar macrophages with visible DWCNT-agglomerate particles.
Fig. 3. DWCNT exposure caused dramatic changes in BALF cytokine levels at 1, 3 and 7 days post DWCNT instillation. Values are given as fold changes relative to controls
(+SEM) at the log scale.
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be associated with increased macrophage and leucocyte accumula-
tion or even a rise in cell activation.
Overall, the biphasic cytokine response was observed, charac-
terised by cytokines with initial high but over time decreasing lev-
els but also those with highest levels at day 1 and 7. This
represents a pattern which matched well with the dynamics of
the neutrophil cell numbers, which also decreased from day 1 to
day 3, but increased again until day 7 (Fig. 2). In contrast to the
mentioned Th1 and acute phase cytokines, the op to day 7still high
Th2 cytokine levels of IL-13 and CCL11 (Eotaxin), with about 200
and 500 pg/ml, might indicate long-term effects related to lung in-
jury beyond the time of investigation. Accordingly, these cytokines
have besides their well-known involvement in allergic inflamma-
tion also been connected to abnormal tissue regeneration as ob-
served during pulmonary fibrosis [36]. In this context, Th2
lymphocyte derived IL-5, and IL13 might contribute to CNT-trig-
gered pulmonary fibrosis.
3.2. DWCNT elicit mild systemic inflammatory changes
The peripheral white blood cell counts were elevated at day 3
and 7 but not day 1 after DWCNT treatment, indicating a moderate
systemic inflammatory response in particular at the later phase
(Fig. 4). In contrast, the percentage of neutrophils in the blood in-
creased at day 1 and 7 only, but had returned to baseline at day 3.
On a related note, the granulocyte stimulating CSF3 was found two
times elevated only at day 1, but CCL5 blood levels display a similar
pattern as the neutrophil amount. Blood concentrations of the T-
cell cytokine IL-9 revealed elevated over all time points relative
to controls, whereas lymphocyte numbers remained constant
(not shown). Over all, the blood cytokine response was much less
expressed in the blood as compared to the lungs (Fig. 5). Though
changes were comparatively moderate (1.5–2-fold), the pattern
and course of up–down–up in the regulation of cytokines was
Fig. 4. DWCNT exposure caused a moderate yet significant increase in the white
blood cell count (WBC) after 3 and 7 days, as well as an elevated fraction of
neutrophil granulocytes in the peripheral blood of DWCNT-treated mice after 1 and
7 days. Statistical significance was analysed by one-way ANOVA and Tukey’s test,
and changes relative to the sham group are highlighted (p < 0.05, p < 0.01).
Fig. 5. Changes of serum cytokine levels at 1, 3 and 7 days post DWCNT instillation, relative to the sham-treated group.
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consistent between the different compartments. A direct commu-
nication between nanotubes challenged pulmonary tissue and
the circulation has previously been described as by means of gene
expression [18,37].
3.3. DWCNT agglomerate uptake by alveolar macrophages but not by
granulocytes
Alveolar macrophages, as professional phagocytes and potent
initiators of inflammation, have been extensively studied, with re-
gard to their responses to various kinds of respirable particulate
matter. In this context, ‘frustrated phagocytosis’ has been
considered as the underlying mechanism of chronic toxicity of
fibre-shaped materials, (e.g. asbestos or particular samples of mul-
ti-walled carbon nanotubes), which follow the classical fibre path-
ogenicity paradigm [10,38]. For less rigid tubes like single- and
double-walled carbon nanotubes, as investigated in this study, a
rather curled but not needle-shaped agglomerate structure was
observed (Fig. 1). Therefore, the relevant pathway of toxicity is
not clear yet.
To elucidate DWCNT cell interactions, we analysed the uptake
of DWCNT agglomerates by the two cardinal professional phago-
cytes, the alveolar macrophages and, upon inflammation, invading
neutrophils. Cell specific antibodies for macrophages, Mac3
(CD107b, LAMP2) and granulocytes, Ly6G/Ly6C (granulocyte
receptor-1) were employed to differentiate macrophages or neu-
trophils on cytospin preparations of BAL cells by immunofluores-
cence. Quantification of BAL leucocytes by optical microscopy
either associated with black CNT agglomerates or without visible
particles was used as an indicator for the internalization of the
mass of instilled carbon material. Cell and fluorescent densities
were quantified, according to the procedure described [30]. As
shown in Fig 6A–D, only macrophages but not neutrophils could
be identified as internalizing CNT agglomerates (Fig. 6A–D). While
the number of BAL macrophages increased from day 1 until day 7
after exposure (Fig. 2), the number of macrophages with engulfed
DWCNT agglomerates remained rather constant (Fig. 6E), suggest-
ing that phagocytosis was not limited by the number of
macrophages.
The fact that Ly6G/Ly6C-positive neutrophils failed to effec-
tively internalize particle agglomerates might be surprising since
Fig. 6. Cellular localisation of DWCNT-agglomerate particles analysed by bright field images superimposed with respective immunofluorescence staining of BAL cell cytospin
preparations. Only macrophages, but not neutrophils, ingested agglomerate-particles. Panels (A) and (C) show bright field images with large DWCNT agglomerates as dark
spots; (B) and (D) show the superimposed immunofluorescence images. Macrophages and neutrophils are stained red by anti-Mac3 (B), or anti-Ly6G/Ly6C (D), and cell nuclei
in blue. Black agglomerate particles (A and C) are displayed by green pseudo colour for illustration (Fig. 6B and D). The histogram shows the number of macrophages with and
without visible DWCNT-agglomerate particles. Statistical significance was analysed by Student’s t-test, and changes between the two groups were indicated (p < 0.001).
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granulocytes are known to effectively phagocytose opsonized par-
ticles, and biodegradation of SWCNTs by neutrophils in vitro has
been described [39]. Kagan and colleagues had already previously
shown that degraded CNTs do not generate an inflammatory re-
sponse when aspirated into the lungs of mice and thus suggest that
the extent to which CNTs are biodegraded may be a major determi-
nant of the scale and severity of the associated inflammatory re-
sponses in exposed individuals. To date, there is still no clear
evidence that neutrophil granulocytes, despite recruited in large
numbers to the site of CNT-injury, can effectively internalize the
nanomaterial and thereby directly contribute to its degradation.
A recent study from Shvedova and colleagues showed the contri-
bution of myeloperoxidase, a lysosomal enzyme most abundantly
expressed in neutrophil granulocytes but to a lesser extent also
in certain macrophages, to oxidative biodegradation of SWCNT
[40]. However, also in their study, no significant uptake of
SWCNT-agglomerates can be detected in neutrophils but only in
macrophages. It might be noteworthy to mention that in all of
our various particle instillation studies, we have never observed
any recognisable amounts of carbon particles associated with gran-
ulocytes [12,41–43].
Since nanoparticles, in general, have been suggested to express
their pro-inflammatory toxicity via their oxidative properties, and
to further characterise the kind of pulmonary injury, we quantified
lung glutathione antioxidant levels as well as the activity of the
antioxidant enzyme catalase. As illustrated in Fig. 7, DWCNT expo-
sure significantly reduced both endogenous antioxidant defence
systems, with the depletion even increasing over time and result-
ing in minimal levels on day 7. Pulmonary deposited carbonaceous
nanoparticles have been described as causing oxidative stress to
the lungs, which has been further related to the inflammatory re-
sponse caused by these materials [44]. So far, there have been only
few studies that have focused on the respiratory toxicity of
DWCNT. Our findings may even contradict the current literature
regarding the involvement of oxidative stress resulting from
DWCNT-caused injury. In this context, Meunier and colleagues de-
scribed a ROS independent, but DWCNTs phagocytosis-dependent
cause of DWCNT triggered inflammation via a cascade of a toll-like
receptor and Nlrp3 inflammasome activation, leading to IL-1b re-
lease in human monocytes [45]. Crouzier et al., on the other hand,
investigated oxidative perturbations using ESR spin trapping
experiments of DWCNT-challenged lungs [46]. In their model, the
authors showed clear signs demonstrating pulmonary and sys-
temic acute inflammatory reactions, which were accompanied by
a decrease in local oxidative stress levels. One major difference be-
tween these two studies and ours is that we have looked at later
time points that exceeded the acute response to get insight into
the potential malfunction of a resolution for pulmonary inflamma-
tion. Another more comprehensive study, which looked into lung
inflammation, fibrosis, oxidative stress and mutagenesis in the
lungs of mice after multi-day exposure to SWCNTs, also supports
our finding of exposure-related depletion of the antioxidant sys-
tem [26]. Metal impurities about 20%, in particular iron and nickel
levels of CNTs, as remain from their synthesis, have been shown to
trigger nanotube exposure related oxidative stress in vitro and
in vivo [22,47]. According to our measurements however, the
Fig. 7. DWCNT exposure caused a progressive depletion of glutathione (GSH) levels
and catalase enzyme activity in lung tissue. Statistical significance was analysed
compared to sham groups.
Fig. 8. Proposed mechanistic scheme associating the dynamic changes in BAL cell numbers with BALF and blood cytokine levels. The upper part depicts the blood
compartment and the lower part the alveolar compartment of the lung, separated by the alveolar-capillary barrier. For simplification, only representative cytokines with
obvious changed levels are shown.
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DWCNT content of 2.45% Fe and 0.02% Ni can hardly explain the
overtime increasing oxidative stress response as illustrated in fig.
7. We therefore rather assume that the persistent inflammatory re-
sponse described here is the main driver of the exhaustion of the
local antioxidant system, by inflammatory radical generating en-
zymes such as monoxigenases, NADPH oxidases or peroxidases,
which are produced and released by inflammatory cells.
4. Proposed scheme of inflammatory response
Our results can be summarised in a schematic illustration of the
dynamic interplay of the different cell types and cytokines during
the course of DWCNT-triggered pulmonary inflammation (Fig. 8).
This figure depicts two parallel, horizontal scenarios, in which
the upper part shows the circulation and the lower part represents
the alveolar compartment of the lung. During the early phase after
alveolar DWCNT deposition, resident alveolar macrophages at-
tempt to phagocytose and, thereby, clear the particulate ‘invader’,
which gives rise to macrophage activation with subsequent cyto-
kine and sustained ROS release (Fig. 8a). Concurrently, cytokines
(such as CCL2, CCL3, IL6 and CSF3) released by macrophages induce
blood monocytes to secrete CSF3 (Fig. 8b) and thus, ultimately, am-
plify the pro-inflammatory response by augmentation and attrac-
tion of granulocytes (day 1, Fig. 8c). The increasing production of
CCL2 and CSF3 chemokines further induces monocyte recruitment
to the lungs, accompanied by subsequent maturation of macro-
phages. Increasing macrophage numbers coincide with the influx
of to the alveoli attracted peripheral leucocytes (Fig. 8) and corre-
spondingly newly recruited macrophages, without obvious CNTs-
inclusion accumulate in the lungs. Increased numbers of by inflam-
matory cytokines activated monocytes/macrophages and granulo-
cytes may now also contribute to the temporal reduction of
cytokine levels by cytokine absorption in the lung and blood on
day 3 (Fig. 8d). From day 3 to day 7, lymphocyte activation and
attraction by IL-9,-12 and CCL5 gather momentum and, accord-
ingly, lymphocytes accumulate in the alveolar region. By day 7,
in the alveolar compartment and circulation, a self-perpetuating
response must apparently have developed. New macrophages
stimulate lymphocytes and granulocytes to maintain a pro-inflam-
matory cytokine response (Fig. 8). Cytokine profiles for IL-9 and
CCL5 are systemically elevated and support the recruitment of
new lymphocytes and monocytes (Fig. 8e). As result, and after
1 week of DWCNT retention, still no effective resolution of pul-
monary inflammation could be archived which divines the forma-
tion of local, but chronic inflammation. This assumption is
supported by the development of multinucleated and giant macro-
phages (Fig. 2), which indicate a failure of particle clearance. In
contrast, we have shown in previous instillation studies, with sim-
ilar dosing but spherical carbon nanoparticles, that the respective
acute pulmonary inflammatory response is completely resolved
within 7 days at the cellular and molecular level [10]. Notwith-
standing that even in the latter case, considerable amounts of the
carbon nanoparticle agglomerates remain in the lungs as well
but do not induce giant cell formation. Future experiments with
prolonged investigation periods should examine these processes
in more detail. In a related context, we have previously described
the inflammatory reaction in responses to pulmonary application
of PEI-based siRNA nanocarriers as an alarming signal with regard
to the biocompatibility of the respective material for pulmonary
drug delivery [48]. Similarly, we think that our DWCNT results
might caution as well against the use of this biopersistent material
for pulmonary drug delivery.
In summary, we have shown that intratracheal exposure to a
dose of 50 lg pluronic-dispersed, pristine DWCNT for each mouse
causes an acute inflammatory response in the lungs and minor
impairment in the blood compartment, which does not resolve
within 1 week after exposure but is accompanied by a significant
and over time aggravating depletion of the pulmonary antioxidant
system. DWCNT agglomerates were phagocytosed by macrophages
but not neutrophil granulocytes, thereby rendering the impact of
the latter on clearance or degradation implausible. In this context,
it needs to be noted that the instilled DWCNT suspension consists
of large agglomerates besides individually dispersed CNTs. This
morphology might be seen as a worst case scenario for either the
pulmonary application of inadequately dispersed, or after inhala-
tion in the lung agglomerated constructs, which must be avoided
in therapeutic approaches.
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